Aveanna Healthcare Holdings Inc (AVAH) — closed signal from June 9, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on September 7, 2026 — +100.3% at the close.
Predicted vs. what happened
AVAH price · publication thesis → realized outcomesplit-adjusted
$6.40 – $6.90Entry zone — fair-value band
$6.78Published — price the day we called it
$7.73Target — the price the thesis aimed for
$14.00Peak — highest point inside the window, not a realized return
$13.58Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 8 days.
At window close
+100.3%
realized, from the publication price to the last close inside the windowPeak gain
+106.5%
peak, from the publication price — not a realized returnS&P 500, same window
+4.8%
SPY over the identical days, dividend-adjustedWindow close
$13.58
last close inside the window, ended September 7, 2026Peak price
$14.00
peak on August 27, 2026 — not a realized returnDays to target
8
The thesis — published June 9, 2026
Predicted growth
+14%
over the measurement windowTarget price
$7.73
the price the thesis aimed forEntry zone
$6.40 – $6.90
the fair-value band we waited forPrice at publication
$6.78
published June 9, 2026Confidence
66%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Aveanna is a higher-risk chance to benefit from a recovery. Buying a smaller home-health company and raising revenue guidance give a clear reason to expect improvement, and recent results show progress from a low valuation. Major risks are high debt, limited stock liquidity, and fragile market interest, so short-term outcomes are uncertain.
Primary drivers
- Acquisition increases company size and scale
- Higher guidance makes future results clearer
- Recent results show the turnaround is happening
- High debt and thin trading raise downside risk
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.